{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:03:50Z","timestamp":1785153830486,"version":"3.55.0"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To compare the efficacy (as measured by time to resolution of pain) and safety of valproate infusion and lidocaine infusion in the treatment of pediatric status migrainosus.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We conducted a single-center retrospective cohort study from March 2014 to June 2021 evaluating children and adolescents who received a lidocaine or sodium valproate infusion for the treatment of status migrainosus. During the study period, lidocaine infusion was exclusively used before March 2016, whereas sodium valproate infusion was exclusively used afterward.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A total of 31 patients received lidocaine and 63 received sodium valproate infusion. Patients in the lidocaine group achieved significantly faster control of pain with median hours to pain free of 11.7 (interquartile range, 3.8\u201332.3) hours compared with 43.4 (interquartile range 13.8\u201368.7) hours in the valproate group (P = .002). At discharge, 21 of 31 (67.7%) of patients receiving lidocaine were pain-free compared with 26 of 59 (44.1%) of patients receiving valproate (P = .03). There were significantly more infusion interruptions of valproate compared with lidocaine for various patient-related factors (16\/63, 25.4% vs 1\/31, 3.2%; P = .009). More adverse effects were observed with valproate (42\/63, 67%) compared with lidocaine (1\/31, 3.2%; P &amp;lt; .001). The significant difference in hours to pain control persisted after adjustment for sex, race, age, BMI, presence of comorbidities, and pain score at admission. All patients in both groups completed the infusions and were discharged from the hospital.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Intravenous lidocaine infusion is associated with superior pain control and a better safety profile compared with intravenous sodium valproate infusion in status migrainosus.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2023-007593","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T08:06:05Z","timestamp":1718093165000},"page":"541-547","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of Lidocaine Infusion Versus Valproate Infusion for Pediatric Status Migrainosus"],"prefix":"10.1542","volume":"14","author":[{"suffix":"Jr","given":"Marco Antonio","family":"Ayulo","sequence":"first","affiliation":[{"name":"aDivisions of Pediatric Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharaya","family":"Jenkins","sequence":"additional","affiliation":[{"name":"bDepartment of Nursing, Department of Pediatrics, Fountain Valley Regional Hospital and Medical Center, Fountain Valley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Le","sequence":"additional","affiliation":[{"name":"cPediatric Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Tripathi","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, University of Illinois College of Medicine at Peoria\/OSF HealthCare, Children\u2019s Hospital of Illinois at Peoria, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"issue":"12","key":"2024070102502955500_B1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1212\/01.WNL.0000147332.41993.90","article-title":"Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society","volume":"63","author":"Lewis","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"2024070102502955500_B2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/WNL.0000000000008095","article-title":"Practice guideline update summary: acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"93","author":"Oskoui","year":"2019","journal-title":"Neurology"},{"issue":"10","key":"2024070102502955500_B3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/head.12701","article-title":"Pediatric inpatient headache therapy: what is available","volume":"55","author":"Kabbouche","year":"2015","journal-title":"Headache"},{"key":"2024070102502955500_B4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pediatrneurol.2017.10.023","article-title":"Sociodemographic factors associated with hospital care for pediatric migraine: a national study using the kids\u2019 inpatient dataset","volume":"91","author":"Recober","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"5","key":"2024070102502955500_B5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/head.14117","article-title":"Dihydroergotamine infusion for pediatric refractory headache: a retrospective chart review","volume":"61","author":"Srouji","year":"2021","journal-title":"Headache"},{"issue":"2","key":"2024070102502955500_B6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1526-4610.2008.01281.x","article-title":"Intravenous lidocaine in the treatment of refractory headache: a retrospective case series","volume":"49","author":"Rosen","year":"2009","journal-title":"Headache"},{"issue":"4","key":"2024070102502955500_B7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5694\/j.1326-5377.2000.tb125538.x","article-title":"Intravenous lignocaine infusions for severe chronic daily headache","volume":"172","author":"Hand","year":"2000","journal-title":"Med J Aust"},{"issue":"1","key":"2024070102502955500_B8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11916-006-0009-z","article-title":"Intravenous treatment of chronic daily headaches in the outpatient headache clinic","volume":"10","author":"Krusz","year":"2006","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"2024070102502955500_B9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1468-2982.2003.00623.x","article-title":"Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse","volume":"23","author":"Williams","year":"2003","journal-title":"Cephalalgia"},{"issue":"3","key":"2024070102502955500_B10","doi-asserted-by":"crossref","first-page":"e0120229","DOI":"10.1371\/journal.pone.0120229","article-title":"Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial","volume":"10","author":"Mazaheri1","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"2024070102502955500_B11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.15441\/ceem.16.199","article-title":"Single-dose intravenous sodium valproate (Depakine) versus dexamethasone for the treatment of acute migraine headache: a double-blind randomized clinical trial","volume":"4","author":"Karimi","year":"2017","journal-title":"Clin Exp Emerg Med"},{"issue":"3","key":"2024070102502955500_B12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ajem.2012.10.014","article-title":"A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache","volume":"31","author":"Bakhshayesh","year":"2013","journal-title":"Am J Emerg Med"},{"issue":"8","key":"2024070102502955500_B13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/PCC.0000000000001629","article-title":"Safety and efficacy of IV lidocaine in the treatment of children and adolescents with status migraine","volume":"19","author":"Ayulo","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"2024070102502955500_B14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/NRL.0000000000000161","article-title":"Continuous intravenous valproate as abortive therapy for pediatric status migrainosus","volume":"23","author":"Zafar","year":"2018","journal-title":"Neurologist"},{"issue":"4","key":"2024070102502955500_B15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1592\/phco.27.4.519","article-title":"Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients","volume":"27","author":"Taylor","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2024070102502955500_B16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40263-015-0304-5","article-title":"Pharmacokinetics and clinical utility of valproic acid administered via continuous infusion","volume":"30","author":"Cook","year":"2016","journal-title":"CNS Drugs"},{"issue":"11","key":"2024070102502955500_B17","doi-asserted-by":"crossref","first-page":"e29215","DOI":"10.1002\/pbc.29215","article-title":"Lidocaine infusions and reduced opioid consumption-Retrospective experience in pediatric hematology and oncology patients with refractory pain","volume":"68","author":"Anghelescu","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2024070102502955500_B18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/pme.12333","article-title":"Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: a preliminary report","volume":"15","author":"Mooney","year":"2014","journal-title":"Pain Med"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/14\/7\/541\/1671614\/hpeds.2023-007593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/14\/7\/541\/1671614\/hpeds.2023-007593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T02:50:47Z","timestamp":1719802247000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/14\/7\/541\/197488\/Effectiveness-of-Lidocaine-Infusion-Versus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,11]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2023-007593","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]}}}